Logo

BioReference Laboratories

Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand

The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing.

BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB

The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season.

Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing

The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes.

How Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
Premium

While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms.

Opko Health Q3 Revenues Up 87 Percent

The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter.

Aug 12, 2020

GeneDx Inks Neonatal Genomic Services Deal With Pediatrix Medical Group

Mar 14, 2020

Trump Administration Highlights Role of Private Sector in Effort to Increase Coronavirus Testing

Mar 13, 2020

BioReference Partners With NY State to Provide Drive-Through SARS-CoV-2 Testing

Mar 5, 2020

Commercial Labs Step up Coronavirus Test Efforts After FDA Guidance

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Apr 3, 2019

NIPT Laboratories Don't Follow All ACMG Recommendations for Reporting, Patient Education

Aug 28, 2018

BioReference Labs' GenPath to Participate in NCI-MATCH

Jun 22, 2018

Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework
Premium

Jan 12, 2018

GeneDx, Radboud UMC Collaborate on Research Into Neurodevelopmental Disorders

Nov 22, 2017

Longstanding Genetic Testing Website GeneTests Closing

Sep 19, 2017

BioReference, The Garage Form Alliance to Advance Patient Care

Jun 7, 2017

UC Health to Have Expanded Access to GeneDx Tests

Apr 24, 2017

Diaceutics Inks Deal for BioReference Labs Dx Data

Jan 10, 2017

Natera Terminates Bio-Reference Labs NIPT Distribution Agreement

Jan 4, 2017

Genetic Testing Firms Establish NIPT Advocacy Organization

Jan 4, 2017

Natera Files Suit Against Bio-Reference Laboratories for Breach of Contract

Nov 7, 2016

Opko Q3 Revenues Up 108 Percent on Strength of BioReference Sales

Oct 11, 2016

Integrating Molecular Tests With EMRs Seen as Essential to Advancing Precision Diagnostics
Premium

Oct 10, 2016

GeneDx Launches Prenatal Exome Sequencing Test, Plans to Expand Into New Dx Areas
Premium

May 9, 2016

Opko Q1 Revenues Up Nearly Ninefold

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.